Bio-Techne
TECH
297 hedge funds and large institutions have $4.72B invested in Bio-Techne in 2017 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 99 increasing their positions, 105 reducing their positions, and 35 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
17% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 35
6% more capital invested
Capital invested by funds: $4.46B → $4.72B (+$256M)
2% more funds holding
Funds holding: 292 → 297 (+5)
6% less repeat investments, than reductions
Existing positions increased: 99 | Existing positions reduced: 105
6.02% less ownership
Funds ownership: 394.86% → 388.84% (-6%)
19% less call options, than puts
Call options by funds: $557K | Put options by funds: $687K
Top Buyers
Top Sellers
TECH Hedge Fund Activity: Q4 2017 in Review
297 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q4 2017, worth a combined $4.72B — up 5.7% from $4.46B a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new TECH positions and 35 closed out — a net gain of 6 holders — while 99 added to existing stakes and 105 trimmed.
The largest buyer was TimesSquare Capital Management, opening a new position worth an estimated $44.2M. The largest seller was Select Equity Group, cutting an estimated $47M.
- 297 institutional investors held Bio-Techne (TECH) as of Q4 2017, up from 292 in Q3 2017.
- Funds reported $4.72B of Bio-Techne stock for Q4 2017, up 5.7% quarter-over-quarter.
- 41 funds opened new Bio-Techne positions in Q4 2017 and 35 closed out, a net change of +6 holders.
- The largest Bio-Techne buyer in Q4 2017 was TimesSquare Capital Management, an estimated $44.2M added.
- The largest Bio-Techne seller in Q4 2017 was Select Equity Group, an estimated $47M sold.
Based on aggregated 13F filings for Q4 2017.